Skip to main content

The Mineralogy of Asbestos

  • Chapter
  • First Online:

Abstract

Minerals are naturally occurring inorganic compounds of specific chemical composition and crystal structure. Their nomenclature typically stems as an honorific, to indicate a pertinent geographic area or to highlight a distinctive characteristic of the compound. The term asbestos collectively references a group of naturally occurring fibrous minerals which have been exploited in numerous commercial and industrial settings and applications dating to antiquity. Its myriad uses as a “miracle mineral” owe to its remarkable properties of extreme resistance to thermal and chemical breakdown, tensile strength, and fibrous habit which allows it to be spun and woven into textiles. Abundant in nature, it has been mined considerably, and in all continents save Antarctica. The nomenclature concerning asbestos and its related species is complex, owing to the interest held therein by scientific disciplines such as geology, mineralogy and medicine, as well as legal and regulatory authorities. The silicate minerals may have fibrous and nonfibrous habits. The group of asbestos and “asbestiform” minerals shares the common features of occurrence as flexible polyfilamentous bundles, long fiber length, and small fiber diameter. As fibrous silicates, asbestos minerals are broadly classified into the serpentine (chrysotile) and amphibole (crocidolite, amosite, tremolite, anthophyllite, actinolite) series, both of which may also contain allied but nonfibrous forms of similar or even identical chemical composition, nonpathogenic to humans. As such, amphibole minerals in the non-polyfilamentous habit are not classified as asbestos, nor are some other asbestiform amphiboles which are not commercially exploitable. Although generally grouped, classified, and regulated generically as asbestos, the serpentine and amphibole groups have different geologic occurrences and, more importantly, significant differences in crystalline structures and chemical compositions. These in turn impart differences in fiber structure and dimension, as well as biopersistence, leading to marked differences in relative potency for causing disease in humans for the group of minerals known as asbestos. Derived from the Greek term for “unquenchable” or “indestructible,” asbestos is the collective term for a family of naturally occurring fibrous silicates that exist in metamorphic, altered basic, or ultra basic igneous rock. Asbestos and asbestiform minerals are narrowly defined and classified, as will be discussed below. The asbestos minerals have found much utility owing to their common properties of thermochemical and electrical resistance, high tensile strength, and flexibility. Insoluble in water and organic solvents, its fine fibers may be spun and woven into textiles and incorporated into many other types of materials; asbestos has seen literally thousands of industrial applications. The usage of asbestos dates through fact and fable to thousands of years ago. Once believed to have almost magical capabilities, first descriptions document its usage in the manufacture of pottery in Finland ca. 2500 B.C. Additional historical attributions for early asbestos usage include cremation garments for royalty and for embalming the pharaohs of ancient Egypt. Emperor Charlemagne reportedly astonished his guests at a feast by throwing table cloths made from asbestos into a fire from which the garments would be removed clean and unharmed. Medieval alchemists termed the mineral “salamander stone” referring to a mythical fireproof animal, and during these times asbestos was used in suits of armor [1]. Deposits of asbestos in the Ural Mountains led to the development of factories producing asbestos textiles in 1720. In the seventeenth century, fibrous minerals discovered in Germany termed Bergflachs or Bergleder likely contained amphibole asbestos, and by the mid-nineteenth century, some 20 asbestos mines were operating in Europe [2]. In colonial America, asbestos deposits were discovered in Pennsylvania and New England, where it was woven into textiles, and chrysotile was discovered in Quebec, Canada, in 1860 [2]. Significant commercial usage of asbestos did not occur until the latter part of the nineteenth century, with the development of demand for insulation for the burgeoning steam technology. At the turn of the twentieth century, additional applications for the useful minerals had been developed, deposits of amphibole asbestos species had been discovered in South Africa, and asbestos was once more being mined in the Urals, this time in large quantities. Commercial exploitation of asbestos was now global and full blown, and by 1980 over 100 million tons of asbestos had been mined worldwide [2], accompanied by the development of serious health concerns related to its usage. The purpose of this chapter is to describe what the groups of minerals classified as asbestos are from a mineralogic perspective, where they occur, and what are the important distinctions that allow relative differences within members of the asbestos group to have differing potencies on the basis of such differences in terms of inducing injury and producing disease following inhalation. It is well known from animal models that the oncogenic potential of fibrous dust increases following reductions in fiber diameter and decreases with reduction in fiber length, and these considerations are generally more important than the chemical composition of the fibers themselves [3–6]. The longer fibers have more potency to induce cell injury, proliferation, oxidant release, and inflammation. It is also the durability of the fibrous dust that confers biopersistence and the potential to induce malignant disease following deposition of fibers in the peripheral airways and migration of fibers to the serosal membrane. Contemporary usage of asbestos has been curtailed following its wide recognition as a most dangerous substance; it is noteworthy that the health hazards of asbestos date to antiquity as well. Pliny the Elder cautioned against the purchase of quarry slaves from asbestos mines, noting that they tended to die young [1]. Contemporary usage of asbestos is highly variable, although global demand still measures in the millions of metric tons. The European Union, Australia, and Japan are examples of states which enforce national bans on asbestos products; other countries allow its usage and enforce variably stringent regulations on fiber type and permitted levels of exposure. In 2006, six countries (the Russian Federation, the People’s Republic of China, Kazakhstan, Brazil, Canada, and Zimbabwe) contributed to 96 % of the world’s production of asbestos [7, 8] In the USA, asbestos consumption fell to 1,730 metric tons in 2007, chiefly in the form of chrysotile-containing roofing products [8].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Barbalance RC (2004) A brief history of asbestos use and associated health risks. EnvironmentalChemistry.com. http://EnvironmentalChemsitry.com/yogi/environmental/asbestoshistory2004.html. Accessed 1 Aug 2010

  2. Ross M (1981) The geologic occurrences and health hazards of amphibole and serpentine asbestos. Ch 6. In: Veblen DR (ed) Amphiboles and other hydrous pyriboles, reviews in mineralogy, vol 9A. Mineralogical Society of America, Washington, DC, pp 279–323

    Google Scholar 

  3. Davis JMG (1989) Mineral fibre carcinogenesis: experimental data relating to the importance of fiber types, size, deposition, dissolution and migration. In: Bignon J, Peto J, Saracci R (eds) Non-occupational exposure to mineral fibres. IARC Scientific Publication, Lyon, 90, pp 33–45

    Google Scholar 

  4. Mossman BT, Churg A (1998) Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157:1666–1680

    Article  CAS  PubMed  Google Scholar 

  5. Stanton MF, Wrench C (1972) Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 48:797–821

    CAS  PubMed  Google Scholar 

  6. Davis JMG, Jones A (1988) Comparison of the pathogenicity of long and short chrysotile asbestos in rats. Br J Exp Pathol 69:717–737

    Google Scholar 

  7. Virta RL (2006) Worldwide asbestos supply and consumption trends from1900 through 2003. US Geological Survey Circular, Reston, 1298

    Google Scholar 

  8. Virta RL (2008) 2007 minerals yearbook- asbestos. US Geological Survey, Reston

    Google Scholar 

  9. Agency for Toxic Substances and Disease Registry, US Dept of Health and Human Services. Asbestos, Chemical and Physical Information (2001)

    Google Scholar 

  10. Sullivan PA (2007) Vermiculite, respiratory disease and asbestos exposure in Libby Montana: update of a cohort mortality study. Environ Health Perspect 115:579–585

    Article  PubMed  PubMed Central  Google Scholar 

  11. McDonald JC, Harris J, Armstrong B (2004) Mortality in a cohort of miners exposed to fibrous amphibole in Libby Montana. Occup Environ Med 61:363–366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Suzuki Y (1982) Carcinogenic and fibrogenic effects of zeolites: preliminary observations. Environ Res 27:433–445

    Article  CAS  PubMed  Google Scholar 

  13. Pooley FD (1979) Evaluation of fiber samples taken from the vicinity of two villages in Turkey. In: Lemen R, Dement JM (eds) Dusts and disease: occupational and environmental exposures to selected fibrous and particulate dusts. Pathotox, Park Forest South, pp p339–p344

    Google Scholar 

  14. Baris YI (1991) Fibrous zeolite (erionite)-related diseases in Turkey. Am J Ind Med 19:374–378

    Article  CAS  PubMed  Google Scholar 

  15. Dumortier P, Coplu L, Brouke I, Emri S, Selcuk T, de Maertelaer V, De Vuyst P, Baris I (2001) Erionite bodies and fibers in bronchoalveolar lavage fluid of residents of Tuzkoy, Cappadocia, Turkey. Occup Environ Med 58:261–266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ilgren E (2008) The fiber length of Coalinga chrysotile: enhanced clearance due to its short nature in aqueous solution with a brief critique on “short fiber toxicity”. Indoor Built Environ 17(1):5–26

    Article  Google Scholar 

  17. McDonald AD, Case BW, Churg A, Dufresne A, Gibbs GW, Sebastien P, McDonald JC (1997) Mesothelioma in Quebec chrysotile miners and millers: epidemiology and etiology. Ann Occup Hyg 41(6):707–719

    Article  CAS  PubMed  Google Scholar 

  18. Craighead JE, Gibbs A, Pooley F (2008) Mineralogy of asbestos, Ch 2. In: Craighead JE, Gibbs A (eds) Asbestos and its diseases. Oxford University Press, New York, pp 23–38

    Chapter  Google Scholar 

  19. Bernstein DM (2005) Understanding chrysotile asbestos: a new perspective based upon current data. In: Proc IOHA, Pilanesberg J3, pp 1–10

    Google Scholar 

  20. Langer AM (2003) Reduction of the biological potential of chrysotile asbestos arising from conditions of service on brake pads. Regul Toxicol Pharmacol 38:71–77

    Article  CAS  PubMed  Google Scholar 

  21. Berman DW, Crump KS (2008) A meta-analysis of asbestos-related cancer risk that addressed fiber size and mineral type. Crit Rev Toxicol 38(S1):49–73

    Article  CAS  PubMed  Google Scholar 

  22. Pierce JS, McKinely MA, Paustenbach DJ, Finley BL (2008) An evaluation of reported no-effect chrysotile exposures for lung cancer and mesothelioma. Crit Rev Toxicol 38:191–214

    Article  CAS  PubMed  Google Scholar 

  23. Goodman M, Teta MJ, Hessel PA, Garabrant DH et al (2004) Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Ann Occup Hyg 48(4):309–326

    PubMed  Google Scholar 

  24. Meeker GP, Bern AM, Brownfield IK, Lowers HA et al (2003) The composition and morphologies of amphiboles from the Rainy Creek Complex near Libby, Montana. Am Mineral 88:1955–1969

    Article  CAS  Google Scholar 

  25. Wylie AG, Verkouteren JR (2000) Amphibole asbestos from Libby, Montana. Am Mineral 85:1540–1542

    Article  CAS  Google Scholar 

  26. Gibbs GW, Berry G (2008) Mesothelioma and asbestos. Regul Toxicol Pharmacol 52:s223–s231

    Article  CAS  PubMed  Google Scholar 

  27. McDonald JC, Harris J, Armstrong B (2002) Cohort mortality study of vermiculite miners exposed to fibrous talc: an update. Ann Occup Hyg 46(suppl 1):93–94

    Google Scholar 

  28. Skinner HCW et al (1988) Fibrous minerals and synthetic fibers, Ch 2. In: Skinner HCW, Ross M, Frondel C (eds) Asbestos and other fibrous materials: mineralogy, crystal chemistry and health effects. Oxford University Press, New York, pp 20–94

    Google Scholar 

  29. Gibbs AR, Pooley F (2008) Mineral fiber analysis and asbestos-related diseases, Ch 12. In: Craighead JE, Gibbs AR (eds) Asbestos and its diseases. Oxford University Press, New York, pp 299–316

    Chapter  Google Scholar 

  30. Langer AM, Mackler AD, Pooley FD (1974) Electron microscopical investigation of asbestos fibers. Environ Health Perspect 9:63–80

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas A. Sporn MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sporn, T.A. (2014). The Mineralogy of Asbestos. In: Oury, T., Sporn, T., Roggli, V. (eds) Pathology of Asbestos-Associated Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41193-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-41193-9_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-41192-2

  • Online ISBN: 978-3-642-41193-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics